Financial Summary and Combined Balance Sheet
A financial summary of revenue and expenditures for Children's Hospital of Philadelphia during the fiscal years of 2025, 2024 and 2023. (Fiscal year ends June 30.)
| Sources of Revenue | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Net Patient Service Revenue | $4,210,763,000 | $3,816,616,000 | $3,356,084,000 |
| Other Operating Revenue | $367,420,000 | $344,481,000 | $300,918,000 |
| Contributions1 | $218,680,000 | $118,566,000 | $106,115,000 |
| Research | $407,296,000 | $400,532,000 | $393,620,000 |
| Total Sources of Revenue | $5,204,159,000 | $4,680,195,000 | $4,156,737,000 |
| Uses of Revenue | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Salaries, Wages and Employee Benefits | $2,744,118,000 | $2,548,511,000 | $2,332,739,000 |
| Supplies and Expenses | $1,166,726,000 | $1,089,993,000 | $930,441,000 |
| Depreciation | $262,673,000 | $252,817,000 | $257,153,000 |
| Interest | $32,870,000 | $32,376,000 | $22,050,000 |
| Research Expenses | $531,088,000 | $532,561,000 | $490,171,000 |
| Uncompensated Care | $36,583,000 | $33,542,000 | $9,551,000 |
| Provisions for Programmatic Investments | $430,101,000 | $190,395,000 | $114,632,000 |
| Total Uses of Revenue | $5,204,159,000 | $4,680,195,000 | $4,156,737,000 |
Combined Balance Sheet
| Assets | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash and Short-term Investments | $288,523,000 | $339,895,000 | $375,073,000 |
| Receivables | $1,168,467,000 | $1,146,226,000 | $980,401,000 |
| Other Current Assets | $349,766,000 | $293,552,000 | $306,786,000 |
| Total Current Assets | $1,806,756,000 | $1,779,673,000 | $1,662,260,000 |
| Investments | $5,436,532,000 | $4,615,425,000 | $4,247,954,000 |
| Property, Plant & Equipment (Net) | $4,156,586,000 | $3,917,601,000 | $3,653,916,000 |
| Other Assets | $313,401,000 | $274,441,000 | $272,784,000 |
| Total Investment Assets | $9,906,519,000 | $8,807,467,000 | $8,174,654,000 |
| Total Assets | $11,713,275,000 | $10,587,140,000 | $9,836,914,000 |
| Liabilities and Net Assets | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Current Portion of Long-term Debt | $69,365,000 | $523,999,000 | $23,173,000 |
| Accounts Payable and Accrued Expenses | $778,305,000 | $711,195,000 | $687,938,000 |
| Total Current Liabilities | $847,670,000 | $1,235,194,000 | $711,111,000 |
| Long-term Debt | $1,979,876,000 | $1,218,064,000 | $1,419,111,000 |
| Other Liabilities | $430,114,000 | $464,004,000 | $484,980,000 |
| Total Long-term Liabilities | $2,409,990,000 | $1,682,068,000 | $1,904,091,000 |
| Unrestricted Net Assets | $7,472,195,000 | $6,862,286,000 | $6,479,240,000 |
| Donor Restricted Net Assets2 | $983,420,000 | $807,592,000 | $742,472,000 |
| Total Net Assets | $8,455,615,000 | $7,669,878,000 | $7,221,712,000 |
| Total Liabilities and Net Assets | $11,713,275,000 | $10,587,140,000 | $9,836,914,000 |
(1) Includes unrestricted, temporarily restricted and permanently restricted contributions.
(2) Donor restricted net assets combines prior years' temporarily and permanently restricted net assets.